Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • Carbonic Anhydrase
    (1)
  • Cytochromes P450
    (1)
  • Histamine Receptor
    (1)
  • Necroptosis
    (1)
  • transporter
    (1)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Nervous System
    (1)
Filter
Search Result
Results for "

electroshock seizure

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    9
    TargetMol | All_Pathways
  • Isotope Products
    2
    TargetMol | Isotope_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
  • Lvguidingan
    T356382351-05-1
    Lvguidingan is an Anticonvulsant agent.
    • $41
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cyclamic acid sodium
    Sodiumcyclamate, Cyclohexylsulfamicacidsodium
    T38808139-05-9
    Cyclamic acid sodium (Cyclohexylsulfamicacidsodium) is a carbonic anhydrase inhibitor and one of the most widely used artificial sweeteners in food and pharmaceuticals.Cyclamic acid sodium shows moderate anticonvulsant activity in a maximal electroshock convulsive seizure model.Cyclamic acid sodium is used in cancer research.
    • $29
    In Stock
    Size
    QTY
  • (R)-AS-1
    T2032602506367-95-7
    (R)-AS-1 is a selective positive allosteric modulator of excitatory amino acid transporter 2 (EAAT2), with an EC50 of 11 nM. At doses of 60 and 90 mg/kg, (R)-AS-1 enhances spontaneous locomotor activity in mice. It demonstrates anticonvulsant properties in mouse seizure models induced by maximal electroshock (MES), pentylenetetrazole (PTZ), or electric current stimulation (32 or 44 mA), with ED50 values of 66.3, 36.3, 15.6, and 41.6 mg/kg, respectively. This compound is applicable in neurological disease research.
    • $1,520
    6-8 weeks
    Size
    QTY
  • Anticonvulsant agent 7
    T205468
    Anticonvulsant agent 7 (Compound 19) is an orally active, broad-spectrum anticonvulsant demonstrating excellent anticonvulsant activity in the MES (maximum electroshock) and 6 Hz seizure models.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • H3R antagonist 8
    T2130093097193-89-7
    H3R antagonist 8 is a selective non-imidazole histamine H3 receptor antagonist (IC50= 0.35 μM) that also exhibits hERG channel blocking activity (IC50= 0.67 μM). It suppresses seizures by antagonizing the H3 receptor and reduces tonic hindlimb extension (THLE) in mice in the maximal electroshock seizure (MES) model (ED50= 20.21 mg/kg). Additionally, it shortens the total movement distance induced by pentylenetetrazol (PTZ) in AB strain zebrafish larvae. H3R antagonist 8 is applicable in epilepsy research.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • Zonisamide-13C2,15N
    Zonisamide-13C2,15N
    T378471188265-58-8
    Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide (T0267) is an antiepileptic agent.1 It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml.2 In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium current.3 Zonisamide (T0267) inhibits H. pylori recombinant carbonic anhydrase (CA) and the human CA isoforms I, II, and V with Ki values of 218, 56, 35, and 21 nM, respectively.4,5 In mice, it has anticonvulsant activity against maximal electroshock seizure (MES) and pentylenetetrazole-induced maximal, but not minimal, seizures (ED50s = 19.6, 9.3, and >500 mg/kg, respectively). Zonisamide (T0267) (40 mg/kg, p.o.) prevents MPTP-induced decreases in the levels of dopamine , but not homovanillic acid or dihydroxyphenyl acetic acid , and increases MPTP-induced decreases in the dopamine turnover rate in mouse striatum in a model of Parkinson's disease.6 Formulations containing zonisamide have been used in the treatment of partial seizures in adults with epilepsy.
    • $990
    35 days
    Size
    QTY
  • 2-(Isopentylamino)naphthalene-1,4-dione
    T379501607447-79-9
    2-(Isopentylamino)naphthalene-1,4-dione is a vitamin K analog.1It inhibits spasms induced by pentylenetetrazole and tonic hindlimb extension induced by maximal electroshock (MES) in mice (ED50s = 349.2 and 108.1 mg/kg, respectively). It also protects mice against seizures in the 6 Hz psychomotor seizure test (ED50s = 152.7 and 263.7 mg/kg at stimulus intensities of 32 and 44 mA, respectively). 1.Li, X., Himes, R.A., Prosser, L.C., et al.Discovery of the first vitamin K analogue as a potential treatment of pharmacoresistant seizuresJ. Med. Chem.63(11)5865-5878(2020)
    • $159
    35 days
    Size
    QTY
  • Sodium cyclamate-D4
    TMIH-0523
    Sodium cyclamate-D4 is a deuterated compound of Sodium cyclamate. Sodium cyclamate (T38808) has a CAS number of 139-05-9. Cyclamic acid sodium is a carbonic anhydrase inhibitor and one of the most widely used artificial sweeteners in food and pharmaceuticals.Cyclamic acid sodium shows moderate anticonvulsant activity in a maximal electroshock convulsive seizure model.Cyclamic acid sodium is used in cancer research.
    • $342
    7-10 days
    Size
    QTY
  • Cyclamic acid sodium (Standard)
    N-Cyclohexylsulfamic acid sodium salt (Standard)
    TMSM-0831139-05-9
    Cyclamic acid sodium (Standard) is the standard substance of Cyclamic acid sodium, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Cyclamic acid sodium (Cyclohexylsulfamicacidsodium) is a carbonic anhydrase inhibitor and one of the most widely used artificial sweeteners in food and pharmaceuticals.Cyclamic acid sodium shows moderate anticonvulsant activity in a maximal electroshock convulsive seizure model.Cyclamic acid sodium is used in cancer research.
    • $36
    7-10 days
    Size
    QTY